Delayed Diagnosis of Narcolepsy: Family History and Clinical Features as Predictive Factors. [PDF]
Lee EH +7 more
europepmc +1 more source
Symptom improvement with dosing above 9 g of low-sodium oxybate: effectiveness and safety in participants with narcolepsy in the DUET study. [PDF]
Simmons JH +10 more
europepmc +1 more source
Recent Advances and Emerging Pharmacotherapeutic Approaches for Central Hypersomnolence Disorders. [PDF]
Aribindi K, Shende TC, Albertson TE.
europepmc +1 more source
Psychometric properties of the novel patient-reported Functional Impacts of Narcolepsy Instrument (FINI) using data from phase 3 clinical trials in narcolepsy type 1. [PDF]
Romero H +5 more
europepmc +1 more source
A historical overview of the cardiovascular safety of sodium oxybate: clinical trials, clinical experience. [PDF]
Kushida CA.
europepmc +1 more source
Rapid Eye Movement (REM)-Predominant Obstructive Sleep Apnea (OSA) Coexisting With and Initially Obscuring Narcolepsy Type 1: A Nine-Year Longitudinal Case Report. [PDF]
Bouhamdi A +11 more
europepmc +1 more source
Development of Narcolepsy Type 1 Following COVID-19 Infection in a Patient Previously Diagnosed With Idiopathic Hypersomnia: A Case Report. [PDF]
Pham B, Memon T.
europepmc +1 more source
Wilson's Disease Coexisting with Narcolepsy Type 1: Evidence for a Multifactorial Cause of Excessive Daytime Sleepiness from a Case Report. [PDF]
Xu Z, Wang Y, Xu C, Hou Z, Yang W.
europepmc +1 more source
Development and content validity of the Functional Impacts of Narcolepsy Instrument: a novel patient-reported outcome measure for narcolepsy type 1 and type 2. [PDF]
Savva Y +8 more
europepmc +1 more source

